Fairfield Financial Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,121
Closed -$147K 81
2024
Q4
$147K Sell
1,121
-295
-21% -$41.3K 0.05% 76
2024
Q3
$221K Sell
1,416
-73
-5% -$11.8K 0.08% 67
2024
Q2
$232K Buy
+1,489
New +$224K 0.07% 61
2023
Q4
$168K Buy
1,245
+467
+60% +$60.7K 0.06% 81
2023
Q3
$105K Sell
778
-144
-16% -$19.7K 0.04% 94
2023
Q2
$132K Hold
922
0.05% 81
2023
Q1
$128K Buy
922
+13
+1% +$1.75K 0.06% 86
2022
Q4
$123K Hold
909
0.06% 87
2022
Q3
$99.7K Sell
909
-68
-7% -$8.63K 0.05% 88
2022
Q2
$129K Hold
977
0.06% 77
2022
Q1
$130K Buy
+977
New +$117K 0.05% 76

Other funds holding AZN